FI962000A - Menetelmä erikseen ekspressoituvien mRNA:iden identifioimiseksi saman-aikaisesti sekä suhteellisten pitoisuuksien mittaamiseksi - Google Patents

Menetelmä erikseen ekspressoituvien mRNA:iden identifioimiseksi saman-aikaisesti sekä suhteellisten pitoisuuksien mittaamiseksi Download PDF

Info

Publication number
FI962000A
FI962000A FI962000A FI962000A FI962000A FI 962000 A FI962000 A FI 962000A FI 962000 A FI962000 A FI 962000A FI 962000 A FI962000 A FI 962000A FI 962000 A FI962000 A FI 962000A
Authority
FI
Finland
Prior art keywords
cdna
mrna
primers
crna
derived
Prior art date
Application number
FI962000A
Other languages
English (en)
Swedish (sv)
Other versions
FI962000A0 (fi
Inventor
Mark G Erlander
Gregor J Sutcliffe
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of FI962000A publication Critical patent/FI962000A/fi
Publication of FI962000A0 publication Critical patent/FI962000A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI962000A 1993-11-12 1996-05-10 Menetelmä erikseen ekspressoituvien mRNA:iden identifioimiseksi saman-aikaisesti sekä suhteellisten pitoisuuksien mittaamiseksi FI962000A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/152,482 US5459037A (en) 1993-11-12 1993-11-12 Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
PCT/US1994/013041 WO1995013369A1 (en) 1993-11-12 1994-11-14 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS

Publications (2)

Publication Number Publication Date
FI962000A true FI962000A (fi) 1996-05-10
FI962000A0 FI962000A0 (fi) 1996-05-10

Family

ID=22543116

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962000A FI962000A0 (fi) 1993-11-12 1996-05-10 Menetelmä erikseen ekspressoituvien mRNA:iden identifioimiseksi saman-aikaisesti sekä suhteellisten pitoisuuksien mittaamiseksi

Country Status (9)

Country Link
US (6) US5459037A (fi)
EP (1) EP0726946B1 (fi)
JP (1) JPH09509306A (fi)
AT (1) ATE251220T1 (fi)
CA (1) CA2174966A1 (fi)
DE (1) DE69433210D1 (fi)
FI (1) FI962000A0 (fi)
NO (1) NO961902L (fi)
WO (1) WO1995013369A1 (fi)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
US5545522A (en) 1989-09-22 1996-08-13 Van Gelder; Russell N. Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
US6096503A (en) * 1993-11-12 2000-08-01 The Scripps Research Institute Method for simultaneous identification of differentially expresses mRNAs and measurement of relative concentrations
US5459037A (en) * 1993-11-12 1995-10-17 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US6110680A (en) * 1993-11-12 2000-08-29 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
RU2111254C1 (ru) * 1994-07-11 1998-05-20 Институт молекулярной биологии им.В.А.Энгельгардта РАН СПОСОБ ДЕТЕКЦИИ ДИФФЕРЕНЦИАЛЬНО ЭКСПРЕССИРУЮЩИХСЯ МАТРИЧНЫХ РНК И КЛОНИРОВАНИЯ СООТВЕТСТВУЮЩИХ ИМ ФРАГМЕНТОВ кДНК
IT1275909B1 (it) * 1995-03-07 1997-10-24 Mirella Pilone Frammento di dna codificante d-amminoacido ossidasi
US5707807A (en) * 1995-03-28 1998-01-13 Research Development Corporation Of Japan Molecular indexing for expressed gene analysis
US6395887B1 (en) 1995-08-01 2002-05-28 Yale University Analysis of gene expression by display of 3'-end fragments of CDNAS
US5712126A (en) * 1995-08-01 1998-01-27 Yale University Analysis of gene expression by display of 3-end restriction fragments of CDNA
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5972693A (en) * 1995-10-24 1999-10-26 Curagen Corporation Apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US6418382B2 (en) 1995-10-24 2002-07-09 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US5871697A (en) * 1995-10-24 1999-02-16 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
WO1997029211A1 (en) * 1996-02-09 1997-08-14 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services RESTRICTION DISPLAY (RD-PCR) OF DIFFERENTIALLY EXPRESSED mRNAs
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) * 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
WO1998008981A1 (en) * 1996-08-30 1998-03-05 Life Technologies, Inc. METHODS FOR IDENTIFICATION AND ISOLATION OF SPECIFIC NUCLEOTIDE SEQUENCES IN cDNA AND GENOMIC DNA
PL332413A1 (en) 1996-09-27 1999-09-13 Guilford Pharm Inc Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals
US6013437A (en) * 1996-11-12 2000-01-11 Qbi Enterprises, Ltd. Method for identifying translationally regulated genes
JP2002515754A (ja) * 1996-11-12 2002-05-28 キュービーアイ エンタプライジズ リミテッド 翻訳的に制御される遺伝子の同定方法
WO1998024935A1 (en) * 1996-12-06 1998-06-11 Urocor, Inc. Diagnosis of disease state using mrna profiles
US6461814B1 (en) 1997-01-15 2002-10-08 Dominic G. Spinella Method of identifying gene transcription patterns
US5968784A (en) * 1997-01-15 1999-10-19 Chugai Pharmaceutical Co., Ltd. Method for analyzing quantitative expression of genes
US6306588B1 (en) 1997-02-07 2001-10-23 Invitrogen Corporation Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
US7332270B1 (en) 1997-03-24 2008-02-19 Urocor, Inc. Diagnosis of disease state using mRNA profiles in peripheral leukocytes
US5958688A (en) * 1997-04-28 1999-09-28 The Trustees Of The University Of Pennsylvania Characterization of mRNA patterns in neurites and single cells for medical diagnosis and therapeutics
WO1998049345A1 (en) * 1997-04-29 1998-11-05 Trustees Of Boston University Methods and compositions for targeted dna differential display
DK0981609T3 (da) * 1997-05-13 2001-11-12 Azign Bioscience As Fremgangsmåde til kloning af mRNA'er og display af differentielt udtrykte transkripter (DODET)
US6261770B1 (en) 1997-05-13 2001-07-17 Display Systems Biotech Aps Method to clone mRNAs
US6373971B1 (en) * 1997-06-12 2002-04-16 International Business Machines Corporation Method and apparatus for pattern discovery in protein sequences
AU727748B2 (en) 1997-08-07 2000-12-21 Curagen Corporation Detection and confirmation of nucleic acid sequences by use of oligonucleotides comprising a subsequence hybridizing exactly to a known terminal sequence and a subsequence hybridizing to an undentified sequence
WO1999028505A1 (en) * 1997-12-03 1999-06-10 Curagen Corporation Methods and devices for measuring differential gene expression
US5945522A (en) * 1997-12-22 1999-08-31 Genset Prostate cancer gene
US6265546B1 (en) 1997-12-22 2001-07-24 Genset Prostate cancer gene
US7189833B2 (en) * 1997-12-22 2007-03-13 Serono Genetics Institute S.A. Prostate cancer gene
ATE236998T1 (de) 1997-12-22 2003-04-15 Genset Sa Prostatakrebs-gen
US5972615A (en) * 1998-01-21 1999-10-26 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
DE19806431C1 (de) 1998-02-17 1999-10-14 Novartis Ag Neues Verfahren zur Identifikation und Charakterisierung von mRNA-Molekülen
IL133673A0 (en) * 1998-05-11 2001-04-30 Quark Biotech Inc Method for identifying genes
DE19822287C2 (de) * 1998-05-18 2003-04-24 Switch Biotech Ag Klonierungsvektor, seine Herstellung und Verwendung zur Analyse von mRNA Expressionsmuster
WO2000018966A2 (en) * 1998-09-29 2000-04-06 Arch Development Corporation A new strategy for genome-wide gene analysis: integrated procedures for gene identification
US20020012922A1 (en) * 1998-11-04 2002-01-31 Hilbush Brian S. Simplified method for indexing and determining the relative concentration of expressed messenger RNAs
EP1127159A1 (en) * 1998-11-04 2001-08-29 Digital Gene Technologies Inc. METHOD FOR INDEXING AND DETERMINING THE RELATIVE CONCENTRATION OF EXPRESSED MESSENGER RNAs
AU1724000A (en) 1998-11-12 2000-05-29 Nyxis, Inc. Diagnostic assay for cancer
US6750012B1 (en) * 1998-12-21 2004-06-15 Curagen Corporation Method of identifying a psychotropic agent using differential gene expression
US6429302B1 (en) 1999-02-02 2002-08-06 Chiron Corporation Polynucleotides related to pancreatic disease
US20060234246A1 (en) * 1999-02-02 2006-10-19 Chiron Corporation Gene products differentially expressed in cancerous cells
WO2000061738A2 (en) * 1999-04-12 2000-10-19 Digital Gene Technologies, Inc. Differential regulation of gene expression in oncogenic transformation
AU4562700A (en) * 1999-05-05 2000-11-21 European Molecular Biology Laboratory Improved predictive power of rna analysis for protein expression
US6334099B1 (en) 1999-05-25 2001-12-25 Digital Gene Technologies, Inc. Methods for normalization of experimental data
US7838225B2 (en) * 1999-10-29 2010-11-23 Hologic, Inc. Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase
WO2001032928A2 (en) * 1999-11-05 2001-05-10 Phase-1 Molecular Toxicology Methods of determining individual hypersensitivity to an agent
WO2001048242A2 (en) 1999-12-29 2001-07-05 Mergen Ltd. Methods for amplifying and detecting multiple polynucleotides on a solid phase support
WO2001083691A2 (en) * 2000-04-12 2001-11-08 The Cleveland Clinic Foundation System for identifying and analyzing expression of are-containing genes
US6387624B1 (en) * 2000-04-14 2002-05-14 Incyte Pharmaceuticals, Inc. Construction of uni-directionally cloned cDNA libraries from messenger RNA for improved 3′ end DNA sequencing
WO2001096866A1 (en) * 2000-06-14 2001-12-20 Vistagen, Inc. Toxicity typing using liver stem cells
US7300751B2 (en) * 2000-06-30 2007-11-27 Syngenta Participations Ag Method for identification of genetic markers
AU7970401A (en) * 2000-06-30 2002-01-14 Syngenta Participations Ag Method for identification, separation and quantitative measurement of nucleic acid fragments
EP1325118B1 (en) * 2000-10-05 2016-05-25 Riken Oligonucleotide linkers comprising a variable cohesive portion and method for the preparation of polynucleotide libraries by using said linkers.
US6391592B1 (en) * 2000-12-14 2002-05-21 Affymetrix, Inc. Blocker-aided target amplification of nucleic acids
US6727068B2 (en) 2001-01-24 2004-04-27 Syngenta Participations Ag Method for non-redundant library construction
US20030165865A1 (en) * 2001-01-29 2003-09-04 Hinkel Christopher A. Methods of analysis of nucleic acids
DE10114063A1 (de) * 2001-03-22 2002-10-10 Mpb Cologne Gmbh Molecular Pla Neue Pflanzengene und deren Verwendung zur Isolierung von konstitutiven oder induzierbaren Promotoren
ATE536185T1 (de) 2001-03-26 2011-12-15 Dana Farber Cancer Inst Inc Verfahren zur abschwächung von reaktionen auf hautreizende mittel
US6949340B2 (en) 2001-03-28 2005-09-27 Creative Mines Llc Optical phase modulator
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7211404B2 (en) 2001-06-22 2007-05-01 Stem Cells, Inc. Liver engrafting cells, assays, and uses thereof
US20030170695A1 (en) * 2001-06-29 2003-09-11 Liang Shi Enzymatic ligation-based identification of nucleotide sequences
US20030082584A1 (en) * 2001-06-29 2003-05-01 Liang Shi Enzymatic ligation-based identification of transcript expression
WO2003010516A1 (en) * 2001-07-23 2003-02-06 Curagen Corporation Method for identifying a nucleic acid sequence
US20120077196A9 (en) * 2001-09-03 2012-03-29 Guido Krupp Universal method for selective amplification of mRNAs
DE10143106C1 (de) * 2001-09-03 2002-10-10 Artus Ges Fuer Molekularbiolog Vermehrung von Ribonukleinsäuren
DE10240868A1 (de) * 2002-09-04 2004-03-18 Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH Verbesserte Verfahren zur Synthese von Nukleinsäuren
US20050003369A1 (en) * 2002-10-10 2005-01-06 Affymetrix, Inc. Method for depleting specific nucleic acids from a mixture
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20050026175A1 (en) * 2003-07-31 2005-02-03 John Link Devices and methods for isolating RNA
US20050042660A1 (en) * 2003-07-31 2005-02-24 Hall Gerald Edward Devices and methods for isolating RNA
US20060099605A1 (en) * 2004-11-11 2006-05-11 Hall Gerald E Jr Devices and methods for isolating RNA
US7645575B2 (en) 2004-09-08 2010-01-12 Xdx, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
WO2006101487A1 (en) * 2005-03-18 2006-09-28 The Board Of Trustees Of The Leland Stanford Junior University Production and therapeutic uses of th1-like regulatory t cells
US20060270843A1 (en) * 2005-05-26 2006-11-30 Hall Gerald E Jr Methods for isolation of nucleic acids
US7666584B2 (en) * 2005-09-01 2010-02-23 Philadelphia Health & Education Coporation Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer
WO2008021431A2 (en) 2006-08-14 2008-02-21 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
EP2102367A2 (en) 2006-11-09 2009-09-23 XDX, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
US9289492B2 (en) 2007-07-17 2016-03-22 The General Hospital Corporation Collecting ovarian cancer stem cells from ovarian cancer cells
WO2010008486A2 (en) 2008-06-24 2010-01-21 Parkinsons Institute Pluripotent cell lines and methods of use thereof
EP3530730B1 (en) * 2011-10-31 2022-07-20 Riken Method for culturing stem cell

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2091225T3 (es) * 1989-07-11 1996-11-01 Gen Probe Inc Metodos para la amplificacion de las secuencias de acidos nucleicos.
ES2138972T3 (es) * 1991-06-14 2000-02-01 Isis Pharmaceuticals Inc Inhibicion por oligonucleotidos antisentido del gen ras.
DE69332665T2 (de) * 1992-03-11 2003-11-27 Dana Farber Cancer Inst Inc Methode um mrna zu klonieren
US6096503A (en) * 1993-11-12 2000-08-01 The Scripps Research Institute Method for simultaneous identification of differentially expresses mRNAs and measurement of relative concentrations
US5459037A (en) * 1993-11-12 1995-10-17 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US6110680A (en) * 1993-11-12 2000-08-29 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5994068A (en) * 1997-03-11 1999-11-30 Wisconsin Alumni Research Foundation Nucleic acid indexing

Also Published As

Publication number Publication date
NO961902L (no) 1996-07-12
CA2174966A1 (en) 1995-05-18
US20030092006A1 (en) 2003-05-15
ATE251220T1 (de) 2003-10-15
JPH09509306A (ja) 1997-09-22
DE69433210D1 (de) 2003-11-06
EP0726946A4 (en) 1999-02-10
US5459037A (en) 1995-10-17
EP0726946B1 (en) 2003-10-01
NO961902D0 (no) 1996-05-10
US6309834B1 (en) 2001-10-30
AU687127B2 (en) 1998-02-19
EP0726946A1 (en) 1996-08-21
AU1055195A (en) 1995-05-29
WO1995013369A1 (en) 1995-05-18
US6030784A (en) 2000-02-29
US5807680A (en) 1998-09-15
US20020127571A1 (en) 2002-09-12
FI962000A0 (fi) 1996-05-10

Similar Documents

Publication Publication Date Title
FI962000A (fi) Menetelmä erikseen ekspressoituvien mRNA:iden identifioimiseksi saman-aikaisesti sekä suhteellisten pitoisuuksien mittaamiseksi
MXPA00012757A (es) Metodo mejorado para identificacion simultanea de arnm expresados diferencialmente y medicion de concetraciones relativas.
Luse et al. Abortive initiation by RNA polymerase II in vitro at the adenovirus 2 major late promoter.
Annunziato Split decision: what happens to nucleosomes during DNA replication?
Willems et al. The regulation of RNA synthesis and processing in the nucleolus during inhibition of protein synthesis
Zhou et al. Palmitoylation and membrane association of the stress axis regulated insert (STREX) controls BK channel regulation by protein kinase C
KR20100063079A (ko) 올리고뉴클레오티드의 탐지 방법
Gerlitz The emerging roles of heterochromatin in cell migration
CN106434982B (zh) 缺血性脑卒中相关的分子标记物及其应用
Holmes et al. Structural requirements for tRNA methylation. Action of Escherichia coli tRNA (guanosine-1) methyltransferase on tRNA (1Leu) structural variants.
EA200100490A1 (ru) Способ индексации и определения относительной концентрации экспрессирующихся информационных рнк
Petering et al. Characterization of the CC chemokine receptor 3 on human keratinocytes
Trivedi et al. Differential regulation of HOXA9 expression by nuclear factor kappa B (NF-κB) and HOXA9
Zhu et al. Regulation of ADAM10 by microRNA-23a contributes to epileptogenesis in pilocarpine-induced Status Epilepticus mice
Dib-Hajj et al. Sodium channel mRNA in the B104 neuroblastoma cell line
Munns et al. Effects of estradiol on uterine ribonucleic acid metabolism. II. Methylation of ribosomal ribonucleic acid and trannsfer ribonucleic acid
De Pooter et al. Cutting edge: Lymphomyeloid-primed progenitor cell fates are controlled by the transcription factor Tal1
Brass et al. Disassociation between acidinsoluble acylcarnitines and ketogenesis following carnitine administration in vivo
HUP9800526A1 (hu) In vitro transzkripciós eljárás természetes anyagok és más kémiai szubsztrátumok szkrinelésére
Grayson et al. Estimation of the half-life of a secretory protein message
Sutcliffe et al. Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
Goto et al. Expression and characterization of Xenopus type I collagen alpha 1 (COL1A1) during embryonic development
Brunel et al. Secondary structure of the 3′ UTR of bicoid mRNA
Jubault et al. Effect of cathodic potential on the electrochemical synthesis of optically active amino-acids
Cannistraro et al. The 5′ ends of Escherichia coli lac mRNA